Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastrointestinal Stromal Tumors × Pharmacogenomic Testing × 1 year × Clear all

Sponsor

Conditions

Neoplasms 2 Waldenstrom Macroglobulinemia 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Solitary Fibrous Tumor, Pleural 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Glioma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Clear Cell 1 Chondrosarcoma 1 Carcinoma, Medullary 1 Cancer Pain 1 Breast Neoplasms 1 Anemia 1 Anatomic Stage III Breast Cancer AJCC v8 1 Adult Patients Who Are Receiving Oncologic Care 1 Adjustment Disorders 1 Adenocarcinoma, Follicular 1

Interventions

Imatinib Mesylate 10 Sunitinib 7 ripretinib 4 Blood Specimen Collection 3 regorafenib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 IDRX-42 2 Biopsy 2 trastuzumab deruxtecan 1 spartalizumab 1 ribociclib 1 pemigatinib 1 palbociclib 1 guadecitabine 1 envafolimab 1 binimetinib 1 avelumab 1 avapritinib 1 atezolizumab 1 Sorafenib 1 Rogaratinib 1 Quality Assurance, Health Care 1 Observation 1 Nivolumab 1 Ipilimumab 1 Everolimus 1 Cyclophosphamide 1 Control Groups 1 Clobetasol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡